Barclays Lowers Molina Healthcare (NYSE:MOH) Price Target to $430.00

Molina Healthcare (NYSE:MOH) had its target price cut by Barclays from $437.00 to $430.00 in a report released on Thursday morning, Benzinga reports. They currently have an equal weight rating on the stock.

Other research analysts have also issued research reports about the stock. Cantor Fitzgerald reaffirmed an overweight rating and issued a $406.00 price target on shares of Molina Healthcare in a research note on Thursday, April 4th. Truist Financial boosted their price objective on shares of Molina Healthcare from $435.00 to $460.00 and gave the stock a buy rating in a research report on Tuesday, February 20th. Wells Fargo & Company cut their price objective on shares of Molina Healthcare from $440.00 to $410.00 and set an equal weight rating on the stock in a research report on Monday, April 15th. StockNews.com lowered shares of Molina Healthcare from a strong-buy rating to a buy rating in a research report on Thursday, February 8th. Finally, Bank of America lowered shares of Molina Healthcare from a neutral rating to an underperform rating and set a $439.00 price objective on the stock. in a research report on Thursday, March 28th. One analyst has rated the stock with a sell rating, four have given a hold rating and five have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the company has an average rating of Hold and a consensus target price of $400.70.

Molina Healthcare Stock Performance

Shares of MOH opened at $342.23 on Thursday. The company has a debt-to-equity ratio of 0.53, a quick ratio of 1.49 and a current ratio of 1.49. Molina Healthcare has a twelve month low of $266.35 and a twelve month high of $423.92. The firm’s 50 day moving average price is $390.34 and its two-hundred day moving average price is $372.35. The firm has a market cap of $20.05 billion, a P/E ratio of 18.57, a PEG ratio of 0.96 and a beta of 0.47.

Molina Healthcare (NYSE:MOH) last announced its quarterly earnings results on Wednesday, April 24th. The company reported $5.73 earnings per share for the quarter, beating analysts’ consensus estimates of $5.46 by $0.27. Molina Healthcare had a net margin of 2.99% and a return on equity of 29.86%. The firm had revenue of $9.93 billion for the quarter, compared to analyst estimates of $9.45 billion. During the same quarter in the previous year, the firm posted $5.81 earnings per share. The business’s revenue was up 21.9% on a year-over-year basis. On average, analysts forecast that Molina Healthcare will post 23.62 EPS for the current fiscal year.

Insiders Place Their Bets

In other Molina Healthcare news, Director Richard M. Schapiro sold 711 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the sale, the director now directly owns 12,207 shares of the company’s stock, valued at $4,688,220.42. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Molina Healthcare news, CFO Mark Lowell Keim sold 15,000 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $386.56, for a total value of $5,798,400.00. Following the transaction, the chief financial officer now directly owns 36,531 shares in the company, valued at $14,121,423.36. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Richard M. Schapiro sold 711 shares of the company’s stock in a transaction on Monday, February 12th. The shares were sold at an average price of $384.06, for a total transaction of $273,066.66. Following the completion of the transaction, the director now owns 12,207 shares in the company, valued at $4,688,220.42. The disclosure for this sale can be found here. Over the last three months, insiders have sold 16,711 shares of company stock valued at $6,472,517. 1.11% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Molina Healthcare

Several institutional investors and hedge funds have recently modified their holdings of MOH. CWM LLC increased its holdings in shares of Molina Healthcare by 8.7% in the third quarter. CWM LLC now owns 1,395 shares of the company’s stock valued at $457,000 after purchasing an additional 112 shares during the last quarter. AE Wealth Management LLC increased its holdings in shares of Molina Healthcare by 33.5% in the third quarter. AE Wealth Management LLC now owns 1,159 shares of the company’s stock valued at $380,000 after purchasing an additional 291 shares during the last quarter. Czech National Bank grew its stake in shares of Molina Healthcare by 47.6% in the third quarter. Czech National Bank now owns 10,189 shares of the company’s stock valued at $3,341,000 after acquiring an additional 3,288 shares in the last quarter. Ballentine Partners LLC grew its stake in shares of Molina Healthcare by 1.4% in the third quarter. Ballentine Partners LLC now owns 2,940 shares of the company’s stock valued at $964,000 after acquiring an additional 41 shares in the last quarter. Finally, Commonwealth Equity Services LLC grew its stake in shares of Molina Healthcare by 1.1% in the third quarter. Commonwealth Equity Services LLC now owns 17,879 shares of the company’s stock valued at $5,862,000 after acquiring an additional 192 shares in the last quarter. 98.50% of the stock is currently owned by institutional investors and hedge funds.

About Molina Healthcare

Molina Healthcare, Inc provides managed healthcare services to low-income families and individuals under the Medicaid and Medicare programs and through the state insurance marketplaces. It operates in four segments: Medicaid, Medicare, Marketplace, and Other. The company served in across 19 states. The company was founded in 1980 and is headquartered in Long Beach, California.